The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: paroxetine     Quarter: 2016Q3

Total Drug/Injury Combinations: 1,702     Number of Pages: 86

DRUGNAME PT EventCount
PAROXETINE MYLAN Depersonalisation/derealisation disorder 3 view events
PAROXETINE MYLAN Depressed mood 3 view events
PAROXETINE MYLAN Diarrhoea 3 view events
PAROXETINE MYLAN Disturbance in attention 3 view events
PAROXETINE MYLAN Drug ineffective 3 view events
PAROXETINE MYLAN Dry mouth 3 view events
PAROXETINE MYLAN Dyskinesia 3 view events
PAROXETINE MYLAN Dyssomnia 3 view events
PAROXETINE MYLAN Energy increased 3 view events
PAROXETINE MYLAN Eye pain 3 view events
PAROXETINE MYLAN Fatigue 3 view events
PAROXETINE MYLAN Flight of ideas 3 view events
PAROXETINE MYLAN Food craving 3 view events
PAROXETINE MYLAN Fungal infection 3 view events
PAROXETINE MYLAN Gait disturbance 3 view events
PAROXETINE MYLAN Hallucination, auditory 3 view events
PAROXETINE MYLAN Hostility 3 view events
PAROXETINE MYLAN Hyperhidrosis 3 view events
PAROXETINE MYLAN Hypersomnia 3 view events
PAROXETINE MYLAN Hypertension 3 view events

Total Drug/Injury Combinations: 1,702     Number of Pages: 86

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)